We are still waiting for these that could come at anytime!!!
“We are very pleased that PAT-DX1 is confirmed to target TNBC tumors, with clear tumor penetration 8 hours after administration. These results provide a foundation for more extensive studies of the effect of PAT-DX1 on TNBC, both as a single agent and in combination with various drugs such as DNA-damaging chemotherapies and PARP inhibitors,” said Dr. James Campbell, Chief Executive Officer and Managing Director of Patrys.
“More complete pharmacokinetic profiling of PAT-DX1 in TNBC is ongoing and will be disclosed when complete”, added Dr. Campbell.
and:-
• Initiate stable cell line development (June)
The BOT!!, page-11
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.258M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $2.652K | 662.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 24059180 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7489761 | 10 |
View Market Depth
| Last trade - 14.10pm 13/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |